Professional Documents
Culture Documents
Buku Alat Gabungan
Buku Alat Gabungan
MONOSIT
ADVIA120
FLOW
4. PLT < 58 X109/ /L 5.0-3500 x103 /µL None
CYTOMETRIC
FLOW
5. RBC < 70.5fl None
CYTOMETRIC
FLOW None
6. MCV < 25.7 pg
CYTOMETRIC
FLOW
7. MCH < 27.0 g/dL None
CYTOMETRIC
FLOW
8. MPV < 6.0 fl None
CYTOMETRIC
FLOW
9. RDW < 11% None
CYTOMETRIC
FLOW
10. GRANULOSIT# < 1.0 g/dL None
CYTOMETRIC
FLOW
11. RETIC < 0.2 % 0.2-24.5 % None
CYTOMETRIC
CELL – DYNE RUBY
Fragile WBC,
FLOW
2. WBC ( WOC ) < 0.10 X109/L 0.02x103 – 246.8x103/µL Neutrophil aggregates, lytic – resistant RBCs,
CYTOMETRIC NRBCs,PLT
Clumps, cryofibrinogen,cryoglobulins
Elevated WBC,
FLOW
3. RBC < 2.0 X1012/L 0.01x106 - 7.16x106 /µL Increase numbers of giant PLT,
CYTOMETRIC Autoagglutination, in vitro hemolysis
Elevated WBC,
FLOW Increase plasma substances ( triglycerides,
4. HGB < 2.0 g/dL 0.0 – 19.9 g/dL
CYTOMETRIC Bilirubin, in vivo hemolysis), lytic – resistant
RBCs
Elevated WBC,
FLOW
5. HCT < 5.0 % 13.0 – 60.0% Hyperglycemia, in vitro hemolysis,increased
CYTOMETRIC
Number of giant PLTs
Elevated WBC,
FLOW Hyperglycemia, in vitro hemolysis,increased
6. MCV < 20 fl 58 – 139 fL
CYTOMETRIC Number of giant PLTs
FLOW
7. MCH < 10 pg
CYTOMETRIC
FLOW
8. MCHC < 35 g/dL
CYTOMETRIC
FLOW
9. RDW < 3.0 %
CYTOMETRIC
WBC fragments, in
FLOW Vitro hemolysis, microtic RBCs,
10. PLT < 5.0 x109/L
CYTOMETRIC cryofibrinogen, cryoglobulins, PLT
clumping, increased number of giant PLT
11. FLOW < 3.0 fl 4.3 – 17.2 fL
CYTOMETRIC
MPV
FLOW
12. RETC < 0.1 % 0.2 – 22.9 %
CYTOMETRIC
SYSMEX XN-1000
FLOW
MCV 0.0
CYTOMETRY
FLOW
MCH 0.0
CYTOMETRY
FLOW
MCHC 0.0
CYTOMETRY
FLOW
RDW -SD 0.0
CYTOMETRY
FLOW
RDW-CV 0.0
CYTOMETRY
FLOW
PDW 0.0
CYTOMETRY
FLOW
MPV 0.0
CYTOMETRY
FLOW
P-LCR 0.0
CYTOMETRY
FLOW
NRBC# 0.0
CYTOMETRY
FLOW
NRBC% 0.0
CYTOMETRY
FLOW
NEUT# 0.0
CYTOMETRY
FLOW
LYMPH# 0.0
CYTOMETRY
FLOW
MONO 0.0
CYTOMETRY
FLOW
EO 0.0
CYTOMETRY
FLOW
BASO# 0.0
CYTOMETRY
FLOW
NEUT % 0.0
CYTOMETRY
FLOW
LYMPH % 0.0
CYTOMETRY
FLOW
MONO % 0.0
CYTOMETRY
FLOW
EO % 0.0
CYTOMETRY
FLOW
BASO % 0.0
CYTOMETRY
FLOW
IG# 0.0
CYTOMETRY
FLOW
IG# 0.0
CYTOMETRY
FLOW
WBC-BF 0.0
CYTOMETRY
FLOW
RBC-BF 0.0
CYTOMETRY
FLOW
MN 0.0
CYTOMETRY
FLOW
PMN 0.0
CYTOMETRY
FLOW
MN% 0.0
CYTOMETRY
FLOW
PMN% 0.0
CYTOMETRY
FLOW
TC-BF#
CYTOMETRY
N ALAT PARAMETER METODE RANGE INTERFERENCE
O
STAGO PT Elektro mekanik 11-12.5 detik HCT > 55%
Starmax N Memanjang pada :
Terapi Vitamin K antagonis, antibiotics
( streptomisin, Kanamisin,Kloramfenikol),
Antikoagulan ( warfarin ), Heparin,
fenibutazon, kuinidin, sulfonamide.
Penyakit hati,afibrinogemia, defisiensi
factor koaulasi,hemorraghic disease of the
newborn (HDN). Gangguan reabsorbsi
usus.
Memendek pada :
Tromboplebitis, infark
miokardial,embolisme pulmonal, pengaruh
terapi barbiturate, digitalis, diuretic,
kontrasepsi oral, rifampisin,
metaproterenol.
Memendek pada :
Tromboplebitis, infark
miokardial,embolisme pulmonal, pengaruh
terapi barbiturate, digitalis, diuretic,
kontrasepsi oral, rifampisin,
metaproterenol.
Memendek pada :
Penyakit hati ( Sirosis hati ), Leukimia,
VonWillebrand, malaria, koagulopati
konsumtif, DIC, terapi heparin, Coumadin.
INR Elektro mekanik < 1.5 Hanya boleh digunakan setelah respon
1.5-2.0 Low pasien stabil terhadap warfarin ( minimal
Intensity satu minggu terapi ). Standar INR tidak
2.0-3.0 Mod boleh digunakan jika pasien baru mulai
Intensity terapi warfarin untuk menghindari hasil uji
2.5-3.5 High yang salah.
Intensity
3.0-4.0 High
Intensity
5 Common
Critical Value
10 Common
Upper Limit
D Dimer Spektrofotometr 0.27-20 µ/ml Hemoglobin ( up to 2g/l)
i Conjugated bilirubin ( up to 290 mg/l),
unconjugated Bilirubin ( up to 200 mg/l)
Unfractionated heparin ( up to 2 IU/ml),
low molecular weight heparin ( up to 2 anti
– Xa IU /ml )
METODE ALAT KIMIA
N NAMA
O ALAT PARAMETER METODE RANGE LOD INTERFERENCE
1 Cobas Lower
Conjugated bilirubin > 274
C311 detection
mmol/L or 16 mg/dL;
limit of
Unconjugated bilirubin >
the test
239 mmol/L or 14 mg/dL),
0.1
Hemolysis >435 umol/L or
Enzymatic 0.1-20.7 mmol/L mmol/L
700 mg/dl, Lipemia >L
colorimetric (3.86-800 (3.86
index 2000
Cholesterol method mg/dL) mg/dL)
Lower
Bilirubin > 1026 mmol/L
detection
or 60 mg/dL, Heinolysis >
limit of the
621 mmol/L or 1000
0.11-41.6 test 0.11
mg/d, Lipemia (dari
mmol/L (2- mmol/L (2
intralipid) >625 mg/dL
Glukosa Heksokinase 750 mg/dL) mg/dL)
Lower
detection Bilirubin > 1026 mmol/L
limit of or 60 mg/d, Hemolysis >
5-700 U/L the test 5 56 mmol/L or 90 mg/dL,
(0.08-11.7 U/L (0.08 Lipemia >500 mg/dL
AST/SGOT UV-Test ukat/L) ukat/L)
Lower
detection Bilirubin > 1026 mmol/L
limit of or 60 mg/d, Hemolysis >
5-700 U/L the test 5 56 mmol/L or 90 mg/dL,
(0.08-11.7 U/L (0.08 Lipemia >500 mg/dL
ALT/SGPT UV-Test ukat/L) ukat/L)
Conjugated bilirubin:
855umol/L or 50mg/dL
Lower and unconjugated
detection bilirubin: 342umol/L or
limit of 20 mg/dL) Hemolysis>
Enzymatic 3-1200 U/L the test 3 124 pmol/L or 200
colorimetric (0.05-20.0 U/L (0.05 mg/dL, lipemia >500
GGT assay ukat/L) ukat/L) mg/dL
Lower
detection Bilirubin > : 1026
limit of umol/L or 60 mg/dL
the test 5 Hemolysis > 124
5-1200 U/L U/L umol/L or 200 mg/dL,
Colorimetric (0.084-20 0 (0.084 Lipemia (dari intralipid)
ALP assay ukat/L) ukat/L) >L index of 2000.
Bilirubin Total Diazo method Lower Hemolysis > 310
0.1-35.0 detection umol/L or 500
mg/dL, limit of mg/dL, Lipemia > L
70.0 mg/dL the test index of 600
(ReRun) 1.7
umol/L
(0.1
mg/dL)
Lower
detection
limit of
the test
0 - 15.0 1,2 Hemolysis > 15.5
mg/dL, > 18 umol/L umol/L or 25
mg/dL (Re- (0.07 mg/dL, Lipemia > L
Bilirubin Direct Diazo method Run) mg/dL) index of 750
Lower
detection Bilirubin(unconjugated) >
limit of 342 umol/L or 20 mg/dL,
the test Hemolysis 311 >umol/L or
Colorimetric 2.0-12.0 2.0 g/L 500 mg/dL, Lipemia >L
Total Protein assay g/dL (0.2 g/dL) index 2000
Conjugated
bilirubin >1026
umol/L or 60
mg/dL,
0.1-
0.1 uncojugated
10.0
mmol/L bilirubin 855
mmol/L
(8.85 umol/L or 50
(8.85-885
mg/dL) mg/dL, Hemolysis
mg/dL)
>248 umol/L or
Enzymatic 400 mg/dL,
colorimetric Triglycerides >
Trigliserida assay 3000mg/dL
Conjugated bilirubin
>513 umol/L or 30mg/dL
and Unconjugated
bilirubin 1026 umol/L or
60mg/dL, Hemolysis
Homogenous 0.08 >745 umol/L or 1200
enzymatic 0.08 - 3.12 mmol/L mg/dL, Triglycerides
colorimetric mmol/L (3- (3 >13.7 mmol/L or l200
HDL cholesterol test 121 mg/dL) mg/dL) mg/dL
Conjugated bilirubin and
Unconjugated bilirubin
>1026 umol/L or
Homogenous 0.10 - 14.2 0.10 60mg/dL, Hemolysis
enzymatic mmol/L mmol/L >621 umol/L or 1000
colorimetric (3.86-548 (3.86 mg/dL, Lipemia > L index
LDL cholesterol test mg/dL) mg/dL) 200
Conjugated bilirubin and
Unconjugated bilirubin
0.2 - 25.0 0.2 >684 umol/L or 40
Enzymatic mmol/L mmol/L mg/dL, Hemolysis >621
colorimetric (11.9-1487 (11.9 umol/L or 1000 mg/dL,
Uric Acid test mg/dL) mg/dL) Lipemia > L index 1500
Creatine UV-Test 7-2000 U/L 7 U/L Conjugated bilirubin and
Kinase (0.12-33.4 (0.12 Unconjugated bilirubin
>1026 umol/L or
60mg/dL, Hemolysis
>124 umol/L or 200
mg/dL, Lipemia > L index
ukat/L) ukat/L) 1000
0.5 Conjugated bilirubin and
Kinetic test 0.5-40 mmol/L Unconjugated bilirubin
with urease mmol/L (3.0- (3.0 mg/dL >1026 umol/L or
and 240 mg/dL urea, 1.4 60mg/dL, Hemolysis
glutamate urea, 1.4-112 mg/dL >621 umol/L or 1000
dehydrogenas mg/dL urea urea mg/dL, Lipemia > L index
Ureum e nitrogen) nitrogen) 1000
2 Archite Bilirubin > 30mg/dL,
ct Plus Hb > 1000 mg/dL,
C4000 5- 800 Intralipid > 1000
Glucose Heksokinase mg/dL 2.5 mg/dL mg/dL
Bilirubin > 30mg/dL,
Hb > 62 mg/dL,
AST/SGOT NADH 0-913 U/L 2 U/L Intralipid > 550 mg/dL
Bilirubin > 30mg/dL,
Hb > 750 mg/dL,
ALT/SGPT NADH 0-942 U/L 2 U/L Intralipid > 550 mg/dL
L-Gamma-
glutamy1-3- Bilirubin > 30mg/dL,
carboxy-4- Hb > 250 mg/dL,
nitroanilide Intralipid > 1000
GGT Substrate 0-1543 U/L 2.5 U/L mg/dL
Bilirubin > 30mg/dL,
PNPP AMP Hb > 750 mg/dL,
ALP BUFFER 0-2200 U/L 5 U/L Intralipid > 750 mg/dL
Bilirubin > 31mg/dL,
0.1-15.0 Hb > 125 mg/dL, TG
Bilirubin Total Diazo Reaction mg/dL 0.04 mg/dL > 519 mg/dL
Spectrophot 0-51.1 0.03 Hb > 250 mg/dL, TG
Bilirubin Direct metric mg/dL mg/dL > 750 mg/dL
Bilirubin > 30mg/dL,
Hb > 125 mg/dL,
Total Protein Biuret 0-18.4 g/dL 0.5 g/dL Intralipid > 750 mg/dL
Bilirubin > 30mg/dL,
Hb > 750 mg/dL,
Bromcresol Intralipid > 1000
Albumin Green 0.4-10.5 g/dL 0.3 g/dL mg/dL
Bilirubin > 30mg/dL,
Hb > 1000 mg/dL,
Urea Nitrogen Urease 0-125 mg/dL 0.7 mg/dL Intralipid > 750 mg/dL
Creatinin Alkaline picrate- 0-38.7 mg/dL 0.05 mg/dL Bilirubin > 3.8mg/dL,
kinetic rate Hb > 500 mg/dL,
blanked Intralipid > 750
mg/dL, ascorbate 1.5
mg/dL, glucose 300
mg/dL, protein 9 g/dL
Conjugated Bilirubin >
32.6mg/dL,
Unconjugated
Bilirubin > 32.4mg/dL,
Hb > 1000 mg/dL,
Accelerator Intralipid > 1000
Selective mg/dL, ascorbate 2.9
HDL Detergent 0-180 mg/dL 5 mg/dL mg/dL
Conjugated Bilirubin >
20mg/dL,
Unconjugated
Bilirubin > 20mg/dL,
Liquid Selective Hb > 500 mg/dL,
LDL Detergent 1-800 mg/dL 1 mg/dL ascorbate 50 mg/dL
Bilirubin > 7.5mg/dL,
Hb > 750 mg/dL,
Intralipid > 1000
mg/dL, ascorbate 1.5
Cholesterol Total Enzimatik 0-705 mg/dL 5 mg/dL mg/dL
Bilirubin > 7.5mg/dL,
Hb > 750 mg/dL,
Intralipid > 1000
5.0-1420 mg/dL, ascorbate 1.5
Triglyceride Enzimatik mg/dL 5 mg/dL mg/dL
Conjugated Bilirubin >
50mg/dL,
Unconjugated
Bilirubin > 50mg/dL,
UIBC Ferene 41-500 kg/dL 41 pg/dL Intralipid > 500 mg/dL
Conjugated Bilirubin >
66mg/dL,
Unconjugated
Bilirubin > 66mg/dL,
Hb > 500 mg/dL,
Intralipid >1500
mg/dL, Faktor
Immunoturbidi rheumatoid >550
CRM metry 0.2-320 mg/dL 0.2 mg/dL IU/ml
3 Advia 0-700 Bilirubin > 25mg/dL,
1800 mg/dL, Hemolysis > 500
>1190 mg/d mg/dL, Intralipid >
Glukosa (GLUH) HEKSOKINASE L (ReRun) 0 mg/dL 500 mg/dL
0-1000 U/L,
>6000 U/L Bilirubin > 30mg/dL,
AST/SGOT UV WITH P5P (Rerun) 0 U/L Intralipid > 488 mg/dL
Bilirubin > 30mg/dL,
0—1100 U/L, Hemolysis > 520
>6600 U/L mg/dL, Intralipid >
ALT/SGPT UV WITH PSP (Rerun) 0 U/L 488 mg/dL
GGT Modified IFCC 0-1200 U/L, 0 U/L Bilirubin > 30mg/dL,
>7200 U/L Hemolysis > 1000
mg/dL, Intralipid >
(Rerun) 650 mg/dL
Bilirubin > 30
0—1100
mg/dL , Hemolysis
> 250 mg/dL,
PNPP. AMP Lipemia (dari
U/L
ALP BUFFER 0 U/L intralipid) > 650
mg/dL.
>6600 U/L
(Re
Run)
Asam askorbat > 50
mg/dL ,
Hemolysis > 1000
Bilirubin Total mg/dL, Lipemia
0.1-35.0 0.1
(T- Bil) VANADAT (dari intralipid) >
E OXIDATION 750 mg/dL.
mg/dL mg/dL
>70.0
mg/dL(Re
Run)
0.0-15.0 Asam askorbat >
mg/dL 0 mg/dL 50 mg/dL ,
Bil
VANADA >22.5 Hemolysis > 750
irubin Direct
TE OXIDATION mg/dL mg/dL, Lipemia
(D- BIL)
( (dari intralipid) >
Re Run) 1000 mg/dL.
Bilmlbin (unconjugated) >
25mg/dL, hemolysis
>500mg/dL, Lipemia(dari
intralipid) > 500 mg/dL,
Dextran > 1500 ngdL.
2.0 - 12.0 g/dL,
Biuret, No Serum
Total Protein >24.0 2 g/dL
Blank, End Point
gr/dL(Rerun)
Bilirubin > 30 mg/dL ,
1-6 g/dL
Hemolysis
> 525 mg/dL, Lipemia
Bromcresol >12 /dL (Re
Albumin 1 g/dL (dari intralipid) > 280
Green Run)
mg/dL.
Bilirubin > 30 mg/dL ,
5-150
Hemolysis
Urea Nitrogen Uricase/Pero mg/dL > 250 mg/dL, Lipemia
(UN) xidase (dari intralipid) > 650
mg/dL.
>300
mg/dL(Re
Run)
0.1-25 Bilirubin > 15 mg/dL ,
0.1
mg/dL Hemolysis
>50.0 > 750 mg/dL, Lipemia
Creatlnin JAFFE mg/dL(Re mg/dL (dari intralipid) > 750
Run) mg/dL.
Bilirubin > 30 mg/dL ,
0-20
Hemolysis
> 525 mg/dL, Lipemia
Uricase/Pero
Uric Acid mg/dL 0 mg/dL (dari intralipid) > 280
xidase
mg/dL.
>100 mg/dL
(Re Run)
20-700 U/L Bilirubin > 30
Lactate/N mg/dL , Lipemia (dari
LDH >4200 U/L(Re 20 U/L
AD intralipid) > 650
Run) mg/dL.
Bilirubin > 30
5-115 mg/dL
mg/dL , Hemolysis
> 500 mg/dL,
Lipemia (dari
HDL Katalase 5 mg/dL
intralipid) > 1000
mg/dL.
>230 mg/dL
(Re Run)
Bilirubin
(Conjugated) > 20
mg/dL
, Bilirubin
(Unconjugated) >
32 mg/dL
Katalase Hemolysis > 810
mg/dL, Lipemia
(dari intralipid) >
436 mg/dL
, Lipemia (dari
0-
LDL konsentrat
1000
trigliserid)
> 1009 mg/dL,
m 0
Asam askorbat > 50
g/dL mg/dL
mg/dL.
Cholesterol Bilirubin
0-675
Total (Unconjugated) > 30
mg/dL , Hemolysis >
Direct 525 mg/dL, Lipemia
mg/dL 0 mg/dL
Measure (dari intralipid) > 65
mg/dL.
>1350
mg/dL(Re
Run)
Triglycerides 0-550
Bilirubin
GPO mg/dL 0 mg/dL
(Unconjugated) > 16
>1100
mg/dL , Hemolysis >
mg/dL(Re 525 mg/dL.
Run)
Ion Selective
40- 40
Electrode
Natrium 205 mmol/L
(ISE)
mmol/L
Ion Selective
1.5
Kalium Electrode 1.5-15
mmol/L
4 AVL Ca (ISE) mmol/L
Ion Selective
Electrode
0.2- 0.2 Lithium dosis
Kalsium (ISE)
5.0 mmoI/L mmol/L tinggi
Ion Selective
Natrium Electrode 70 mmol/L
(ISE)
Jokoh
Ion Selective
Electrol
Electrode
5 yte Kalium 1 mmol/L
(ISE)
Analyze
r
Ion Selective
Chloride Electrode 70 mmol/L
(ISE)
Reverse Acetylated Hb
Phase Kation 50mg/dL, Albumin
Exchange 20000mg/dL,
Chromatogra 3% -> 9
Conjugated Bilirubin
phy mmol/L >100mg/dL,
Arkray HbAlc Unconjugated
6
A1c Bilinibin >l00mg/dL
Reverse Carbamylated Hb
Phase Kation 25mg/dL, Labile Hb
Exchange 2000mg/dL,
HbF 0% Rheumatoid Factor
Chromatogra
phy 750 IU/mL
Bilirubin less than
17.9 mg/dL or 306
mmol/L,
Capillary HbA2 0.0— Triglyceride
7 Sebia Electrophores 9.9 %, HbF concentration less
HbA1c is 0.0-713% than 22.34 g/dL
Serum Protein Serum 55.8%,
Electrophoresi Capillary 2.9%, 7.1%,
s: Albumin,
Alpha-1,
Alpha-2, Beta-
1, Beta-2, Electrophores 4.7%, 3.2%,
Gamma is 11.1%
METODE ALAT SEROLOGI
Negatif palsu:
Antibiotik oral )
Obat (ammonium klorida, vit.C),
Paparan sinar UV
Negatif palsu:
Antibiotik oral )
Obat (ammonium klorida, vit.C),
Paparan sinar UV